127 related articles for article (PubMed ID: 8287230)
21. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of methotrexate resistance in osteosarcoma.
Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
[TBL] [Abstract][Full Text] [Related]
25. c-myc amplification and expression in newly established human osteosarcoma cell lines.
Bogenmann E; Moghadam H; DeClerck YA; Mock A
Cancer Res; 1987 Jul; 47(14):3808-14. PubMed ID: 3297309
[TBL] [Abstract][Full Text] [Related]
26. Provirus integration and myc amplification in 90Sr induced osteosarcomas of CF1 mice.
Van der Rauwelaert E; Maisin JR; Merregaert J
Oncogene; 1988 Mar; 2(3):215-22. PubMed ID: 2832803
[TBL] [Abstract][Full Text] [Related]
27. SV40 sequences in human osteosarcoma of German origin.
Heinsohn S; Scholz RB; Weber B; Wittenstein B; Werner M; Delling G; Kempf-Bielack B; Setlak P; Bielack S; Kabisch H
Anticancer Res; 2000; 20(6B):4539-45. PubMed ID: 11205301
[TBL] [Abstract][Full Text] [Related]
28. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
29. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
[TBL] [Abstract][Full Text] [Related]
30. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
31. Sporadic amplification of the c-fms proto-oncogene in human musculoskeletal sarcomas.
Castresana JS; Barrios C; Ruiz J; Gómez L; Kreicbergs A
Anticancer Res; 1993; 13(3):807-10. PubMed ID: 8317916
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
Wu B; Wang M; You W; Yang S
Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
[TBL] [Abstract][Full Text] [Related]
33. Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma.
Ikeda S; Sumii H; Akiyama K; Watanabe S; Ito S; Inoue H; Takechi H; Tanabe G; Oda T
Jpn J Cancer Res; 1989 Jan; 80(1):6-9. PubMed ID: 2496060
[TBL] [Abstract][Full Text] [Related]
34. Multifocal osteosarcoma: an unusual presentation.
Gunawardena S; Chintagumpala M; Trautwein L; Brewer E; Gresik MV; Hicks MJ; Harrison WR; Morad A; Cooley LD
J Pediatr Hematol Oncol; 1999; 21(1):58-62. PubMed ID: 10029815
[TBL] [Abstract][Full Text] [Related]
35. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.
McHugh JB; Thomas DG; Herman JM; Ray ME; Baker LH; Adsay NV; Rabah R; Lucas DR
Cancer; 2006 Aug; 107(3):554-62. PubMed ID: 16795069
[TBL] [Abstract][Full Text] [Related]
36. HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases.
Hansel DE; Swain E; Dreicer R; Tubbs RR
Am J Clin Pathol; 2008 Aug; 130(2):274-81. PubMed ID: 18628098
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
[TBL] [Abstract][Full Text] [Related]
38. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
39. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
40. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
